Strange IndiaStrange India

Diagnostic biomarkers and effective therapies are urgently needed for the millions of people living with long COVID. But the challenges of designing and conducting clinical trials mean that only large, well-funded academic centres can engage with the problem.

Competing Interests

Table of Contents

J.V.W. has received a speaker fee from Pfizer, but none of the authors has a conflict of interest.

Source link


Leave a Reply

Your email address will not be published. Required fields are marked *